Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
06. Februar 2024 08:30 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...